help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 29, 2004
Endocrinology, doi:10.1210/en.2004-1303
A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/4/1883    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glister, C.
Right arrow Articles by Knight, P. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glister, C.
Right arrow Articles by Knight, P. G
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Submitted on October 5, 2004
Accepted on December 21, 2004

Bone morphogenetic proteins (BMP) -4, -6 and -7 potently suppress basal and LH-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling?

Claire Glister, Stephenie L Richards, and Philip G Knight*

School of Animal and Microbial Sciences, The University of Reading, Whiteknights, Reading, RG6 6AJ, UK

* To whom correspondence should be addressed. E-mail: p.g.knight{at}reading.ac.uk.

We reported recently that bovine theca interna cells in primary culture express several type-I and type-II receptors for bone morphogenetic proteins (BMPs). The same cells express at least two potential ligands for these receptors (BMP-4 and -7) while bovine granulosa cells and oocytes express BMP-6. Therefore BMPs of intrafollicular origin may exert autocrine/paracrine actions to modulate theca cell function. Here we report that BMP-4, -6 and -7 potently suppress both basal (P < 0.0001; respective IC50 values 0.61, 0.25, 1.13ng/ml) and LH-induced (P < 0.0001; respective IC50 values 5.00. 0.55, 4.55 ng/ml) androgen production by bovine theca cells while having only a moderate effect on progesterone production and cell number. Semi-quantitative RT-PCR showed that all three BMPs markedly reduced steady-state levels of mRNA for P450c17 levels of mRNA encoding StAR and P450scc and 3{beta}HSD were also reduced but to a much lesser extent. Immunocytochemistry confirmed a marked reduction in cellular content of P450c17 protein following BMP treatment (P < 0.001). Exposure to BMPs led to cellular accumulation of phosphorylated Smad1, but not Smad2, confirming that the receptors signal via a Smad1 pathway. The specificity of the BMP response was further explored by co-incubating cells with BMPs and several potential BMP antagonists, chordin, gremlin and follistatin. Gremlin and chordin were found to be effective antagonists of BMP-4 and -7 respectively and the observation that both antagonists enhanced (P < 0.01) androgen production in the absence of exogenous BMP suggests an autocrine/paracrine role for theca-derived BMP-4 and -7 in modulating androgen production. Collectively, these data indicate that an intrafollicular BMP signaling pathway contributes to the negative regulation of thecal androgen production and that ovarian hyperandrogenic dysfunction could be due to a defective autoregulatory pathway involving thecal BMP signaling.


Key words: BMP • growth factor • theca cell • steroidogenesis • androgen • bovine • ovarian follicle




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. Wachs, M. S. Coffler, P. J. Malcom, S. Shimasaki, and R. J. Chang
Increased Androgen Response to Follicle-Stimulating Hormone Administration in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1827 - 1833.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
F. Cillo, T. A L Brevini, S. Antonini, A. Paffoni, G. Ragni, and F. Gandolfi
Association between human oocyte developmental competence and expression levels of some cumulus genes
Reproduction, November 1, 2007; 134(5): 645 - 650.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. Herath, E. J Williams, S. T Lilly, R. O Gilbert, H. Dobson, C. E Bryant, and I M. Sheldon
Ovarian follicular cells have innate immune capabilities that modulate their endocrine function
Reproduction, November 1, 2007; 134(5): 683 - 693.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S Elis, J Dupont, I Couty, L Persani, M Govoroun, E Blesbois, F Batellier, and P Monget
Expression and biological effects of bone morphogenetic protein-15 in the hen ovary
J. Endocrinol., September 1, 2007; 194(3): 485 - 497.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. L Al-Musawi, R. T Gladwell, and P. G Knight
Bone morphogenetic protein-6 enhances gonadotrophin-dependent progesterone and inhibin secretion and expression of mRNA transcripts encoding gonadotrophin receptors and inhibin/activin subunits in chicken granulosa cells
Reproduction, August 1, 2007; 134(2): 293 - 306.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. De, J.-I. Park, K. Kawamura, R. Chen, C. Klein, R. Rauch, S. M. Mulders, M. D. Sollewijn Gelpke, and A. J. W. Hsueh
Intraovarian Tumor Necrosis Factor-Related Weak Inducer of Apoptosis/Fibroblast Growth Factor-Inducible-14 Ligand-Receptor System Limits Ovarian Preovulatory Follicles from Excessive Luteinization
Mol. Endocrinol., October 1, 2006; 20(10): 2528 - 2538.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
P. G Knight and C. Glister
TGF-{beta} superfamily members and ovarian follicle development.
Reproduction, August 1, 2006; 132(2): 191 - 206.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. G. Farnworth, P. G. Stanton, Y. Wang, R. Escalona, J. K. Findlay, and G. T. Ooi
Inhibins Differentially Antagonize Activin and Bone Morphogenetic Protein Action in a Mouse Adrenocortical Cell Line
Endocrinology, July 1, 2006; 147(7): 3462 - 3471.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. K. Campbell, C. J. H. Souza, A. J. Skinner, R. Webb, and D. T. Baird
Enhanced Response of Granulosa and Theca Cells from Sheep Carriers of the FecB Mutation in Vitro to Gonadotropins and Bone Morphogenic Protein-2, -4, and -6
Endocrinology, April 1, 2006; 147(4): 1608 - 1620.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C. Glister, N. P Groome, and P. G Knight
Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid
J. Endocrinol., February 1, 2006; 188(2): 215 - 225.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. Moll, C. Millet, D. Noel, B. Orsetti, A. Bardin, D. Katsaros, C. Jorgensen, M. Garcia, C. Theillet, P. Pujol, et al.
Chordin is underexpressed in ovarian tumors and reduces tumor cell motility
FASEB J, February 1, 2006; 20(2): 240 - 250.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
B Lohrke, T Viergutz, and B Kruger
Polar phospholipids from bovine endogenously oxidized low density lipoprotein interfere with follicular thecal function
J. Mol. Endocrinol., December 1, 2005; 35(3): 531 - 545.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society